GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Additional Paid-In Capital

Lonza Group (Lonza Group) Additional Paid-In Capital : $2,835 Mil(As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Lonza Group Additional Paid-In Capital?


Lonza Group's quarterly additional paid-in capital declined from Dec. 2022 ($2,772 Mil) to Jun. 2023 ($2,723 Mil) but then increased from Jun. 2023 ($2,723 Mil) to Dec. 2023 ($2,835 Mil).

Lonza Group's annual additional paid-in capital declined from Dec. 2021 ($2,924 Mil) to Dec. 2022 ($2,772 Mil) but then increased from Dec. 2022 ($2,772 Mil) to Dec. 2023 ($2,835 Mil).

Lonza Group Additional Paid-In Capital Historical Data

The historical data trend for Lonza Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Additional Paid-In Capital Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,957.46 3,156.24 2,924.00 2,771.58 2,835.34

Lonza Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,924.00 2,661.31 2,771.58 2,723.23 2,835.34

Lonza Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Lonza Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Lonza Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group (Lonza Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Additional Paid-In Capital
Comparable Companies
XSWX:EMMN XSWX:ARYN XSWX:ORON XSWX:BARN XSWX:BELL XSWX:GMI XSWX:HOCN XSWX:GALD TSE:2309 TMO DHR IQV IDXX A MTD ICLR ILMN WAT SHSE:603259 LH
Traded in Other Exchanges
LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland
Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Website
https://www.lonza.com
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.